The Importance of a Pre-Trip Inspection
Planning a safe trip as a professional truck driver requires thoughtful preparation before every journey. These are key practices to keep in mind throughout each stage of your trip.

ICSA Platinum Membership requirements include the hair testing of drivers for drugs. Why? Because hair testing promotes safety… and it works! Here’s more proof:
A recent study by the University of Central Arkansas compared more than 936,000 truck driver pre-employment urine and hair test results. The tests results were submitted by motor carrier members of The Trucking Alliance, who, like ICSA Platinum Members, utilize hair testing as well as the federally mandated urine tests. University researchers looked at drug test failures from both testing methods.
Result: Urinalysis failed to detect 90% of the drug use revealed by hair testing.
Specifics:
Professional truck drivers are tested for each of these drugs because their presence in the driver’s system can affect perception, muscle control, clear thinking and reaction time – that is, because these drugs can lead to unsafe driving. Recently, the U.S. Department of Transportation approved the use of oral fluids for drug testing, greatly facilitating immediate roadside tests in post-accident situations. Unfortunately, urinalysis and oral fluids testing only reveal drug use in the past one to three days. Hair testing can detect a pattern of drug use up to 90 days.
Highway safety and drug-free truck drivers go hand-in-hand. That’s why ICSA supports the federal approval of hair testing. And that’s why ICSA Platinum Membership includes hair testing as a requirement.
Planning a safe trip as a professional truck driver requires thoughtful preparation before every journey. These are key practices to keep in mind throughout each stage of your trip.
English-language proficiency, non-domiciled truck driver licensing, enforcement of cabotage rules, thorough commercial driver’s license (CDL) training… actions in all of these areas made trucking headlines in the first year of the Trump Administration.
On December 18, 2025, President Trump signed an Executive Order directing the federal government to conduct rulemaking to move marijuana from a Schedule I drug under the Controlled Substances Act (CSA) to Schedule III.